Data from Scottish Intercollegiate Guidelines Network (SIGN) - Curated by EPG Health - Last updated 29 May 2018



Latest update


This guideline covers diagnosis and treatment of colorectal cancer. It summarises the evidence and, where appropriate, provides evidence-based recommendations around: prevention and screening; genetics; referral; diagnosis; surgery; pathology; chemotherapy and radiotherapy; and follow up.

This guideline will be of particular interest to members of the multidisciplinary team treating patients with colorectal cancer (surgeons, oncologists, pathologists, radiologists and nurses), as well as gastroenterologists, general practitioners, patients and their carers.

Read full guideline


You will need to login, to leave a comment. is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Biosimilars in Oncology Knowledge Centre

Biosimilars in Oncology Knowledge Centre

What are biologics and how do they differ from small molecule medicines? Discover more about their development, as well as the manufacturing and regulatory processes in the Biosimilars in Oncology Knowledge Centre.

Inflammatory bowel disease assessment tools

Inflammatory bowel disease assessment tools

'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Load more

Related Content